October 31, 2022
LaTonya Hickson, M.D.: Seeking a cellular therapy for chronic kidney disease
Every year, more than 130,000 people in the U.S. are diagnosed with end-stage kidney disease, with most cases caused by diabetes. Newer therapies show promise to slow kidney failure rates, but none stop progression to end-stage kidney failure. The research goal of LaTonya Hickson, M.D., is to develop a cell-based therapy that slows — or […]
Tags: Center for Regenerative Biotherapeutics, chronic kidney disease, diabetic kidney disease, end-stage kidney disease, LaTonya Hickson, nephrology, stem cell research
April 19, 2021
Mayo Clinic Research in the news — 4/19/2021
This week saw some advances in neurology for patients with memory loss or Parkinson’s disease, as well as furthered understanding of the role race plays in personalized medicine. Read about these, updates on COVID-19, and a number of other findings in health care and biomedical research. Blood-Based Markers Tied to Brain Cell and Memory Loss […]
Tags: acute kidney injury, Amaal Starling, artificial intelligence, brain cancer, brain tumor, chronic kidney disease, clinical trials, cognitive impairment, concussion, COVID-19, Cumara O'Carroll, diversity
April 5, 2021
Mayo Clinic Research in the news — 4/5/2021
Mayo Clinic research and faculty experts were featured in a variety of news stories including 3D printed surgical models, early treatment for smoldering multiple myeloma, and heart attacks in women. Updated guideline highlights new therapies, considerations in anaplastic thyroid cancer Healio, 4/1/2021 An updated guideline for best practices in managing anaplastic thyroid cancer stresses the […]
Tags: 3D printing, Alfredo Quinones-Hinojosa, Alzheimer's disease, artificial intelligence, blood cancer, chronic kidney disease, Clifford Jack Jr., COVID-19, digital health, Eric Moore, genetic testing, genetics
October 28, 2020
Stem cell therapy to repair kidney damage
Mesenchymal stem cells derived from a person’s fat cells may help repair kidney damage caused by narrowing blood vessels, Mayo Clinic research has discovered. The research by Stephen Textor, M.D., and his team is published in Kidney International. Mayo Clinic Center for Regenerative Medicine and the National Institutes of Health supported this first-in-human study to […]
Tags: Center for Regenerative Medicine, chronic kidney disease, mesenchymal stem cells, renovascular disease, stem cell therapy, Stephen Textor